Fundraising Fox
🦊/People
Sign in

Regina Hodits

Investor

Managing Director at Angelini Ventures · Board director at Carisma Therapeutics

Munich

Find your path to Regina

642 people in our graph share verified history with Regina — schools, employers, funds. One of them is your warm intro.

Stephane KurganunlockedRegina: together at McKinsey & Company (1997–1999)
×5Regina: together at McKinsey & Company
Regina: together at Atlas Venture
×4Regina: together at GSK GlaxoSmithKline

About

Regina Hodits is a Managing Director at Angelini Ventures. She previously served as Managing Partner at Wellington Partners Life Sciences and led the European life sciences efforts of Atlas Venture, and earlier worked at Apax Partners and McKinsey. She studied chemical engineering in Vienna, holds a Ph.D. in biochemistry, and conducted post-doctoral research at the MRC in Cambridge, UK.

Contact· published on Regina's own website

Invests in

BiotechDigital HealthMedical Devices

Board director at Carisma Therapeutics

Intro paths

→

In turn, Regina can intro founders to Carisma Therapeutics's investors below.

Carisma Therapeutics's investors · 9

Agent CapitalWaltham · since 2017Aju IB Invesment CorporationSeoul · since 2020Anzu PartnersBillerica · since 2020Grazia Equity GmbHStuttgart · $540K – $2.7M checks · since 2020HealthCapStockholm · since 2020M VenturesLos Angeles · $10.8M checks · since 2021MRL Ventures FundCambridge · $25M checks · since 2020Solasta VenturesBoston · since 2020SymBiosisBentonville · since 2020

Experience

  1. Angelini VenturesManaging Directorcurrent2025 — presentMunich, Germany
  2. Wellington Partners Life SciencesVenture Advisorcurrent2025 — presentMunich, Germany
  3. Wellington Partners Life SciencesManaging Partner2010 — 2025Munich, Germany
  4. INiTS | Vienna's High-Tech IncubatorChairperson of the Board - Pro-Bonocurrent2012 — presentVienna, Austria
  5. BioInnovation InstituteBoard Membercurrent2020 — presentCopenhagen, Denmark
  6. EIT Health GermanyMember of the Expert Council - Pro-Bono2019 — 2024
  7. BVK Bundesverband Deutscher KapitalbeteiligungsgesellschaftenSpokesperson of the Board of Directors2015 — 2020Berlin, Germany
  8. GSK GlaxoSmithKlineExternal Director Respiratory Therapeutic Area Board2008 — 2014London, UK
  9. Atlas VentureGeneral Partner- Life Sciences2004 — 2010Munich GER London UK
  10. Apax PartnersInvestment Manager2000 — 2004Munich, Germany
  11. McKinsey & CompanyEngagement Manager1997 — 2000Vienna AUT / London UK / Munich GER
  12. Medical Research CouncilPost-Doctoral Researcher at Sir Gregory Winter's lab1995 — 1997Cambridge UK
  13. University of Vienna, Institute of BiochemistryScientific Team Leader & University Lecturer1993 — 1995Vienna AUT

Skills & more

Venture Capital22Unternehmensentwicklung15Fusionen und Übernahmen11Biowissenschaften14Corporate Development3Risikoprüfung4Strategisches Management6Start-ups31Biotechnologie6Unternehmensstrategie4Privates Eigenkapital3Pharmaindustrie12
+10 moreUnternehmertumTechnologietransferUnternehmensleitungDue DiligenceBusiness DevelopmentRisikokapitalLife SciencesRiskokapitalGeschäftsentwicklungStrategie

Languages Deutsch · Englisch · Spanisch

From Regina's professional profile.

Investments

Board seats

CarismaMinervaxNitec PharmaNovamedONWARDSeamlessSidekickSidekick HealthSNIPR BiomeStipeTRiCaresU3 Pharma

Investor

Atopix TherapeuticsBicycleCarisma TherapeuticsF-starImcheckJenavalveMiddle Peak MedicalNuclidiumOnwardRigontecSapiensSapiens MedicalSidekick HealthSNIPR BiomeThemisThemis MedicalTricares

Sources: the firm's website · curated public sources.

Colleagues at Angelini Ventures

Elia Stupka
Managing Director at Angelini Ventures
Paolo Di Giorgio
CEO and Managing Director at Angelini Ventures
Tanja Dowe
Managing Director at Angelini Ventures

Network1

Geeta Vemuri
Managing Partner, Founder at Agent Capital

Investors connected to Regina in public investor directories — a warm-intro map.

Frequently asked questions

Who is Regina Hodits?
Regina Hodits is a Managing Director at Angelini Ventures. She previously served as Managing Partner at Wellington Partners Life Sciences and led the European life sciences efforts of Atlas Venture, and earlier worked at Apax Partners and McKinsey. She studied chemical engineering in Vienna, holds a Ph.D. in biochemistry, and conducted post-doctoral research at the MRC in Cambridge, UK.
Where does Regina Hodits work?
Regina Hodits is Managing Director at Angelini Ventures and Board director at Carisma Therapeutics.
What does Regina Hodits invest in?
Regina Hodits invests in Biotech, Digital Health, Medical Devices.
What boards does Regina Hodits sit on?
Regina Hodits holds tracked board seats at Carisma, Minervax, Nitec Pharma, Novamed, ONWARD, Seamless, Sidekick, Sidekick Health, SNIPR Biome, Stipe.
What companies has Regina Hodits invested in?
Investments tracked here include Atopix Therapeutics, Bicycle, Carisma Therapeutics, F-star, Imcheck, Jenavalve, Middle Peak Medical, Nuclidium, Onward, Rigontec, Sapiens, Sapiens Medical, and 5 more.
Where did Regina Hodits go to school?
Regina Hodits studied at Technische Universität Wien (Doctorate of Science / Biochemistry); McKinsey & Company Clearwater, USA (Executive MBA course); Technische Universität Wien (Masters of Science / Chemical Engineering).

Same school

Shared employers